Nicoya Lifesciences Inc.

Nicoya Lifesciences is committed to democratizing access to advanced scientific technologies by designing and manufacturing innovative instruments catered specifically to research scientists across the globe. Their portfolio includes the Digital Surface Plasmon Resonance (SPR) products like Alto and OpenSPR, which are instrumental in the study of binding kinetics and biomolecular interactions. These tools are primarily utilized in the exploration of vaccines, antibodies, proteins, and lipids, finding applications within research labs and teaching environments. With solutions trusted by over 500 research facilities globally, Nicoya Lifesciences also offers a suite of software products like Nicosystem and OpenSPR software to complement their hardware. The company emphasizes fostering cutting-edge research while assisting in navigating challenges like emerging viral variants and the post-COVID research landscape. Nicoya aims to streamline laboratory workflows through automation, enhancing the efficiency and accuracy of biomolecular research tasks.